Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives USFDA Final Approval for Ivabradine Tablets 5 mg and 7.5 mg